background image

Ovarian Cancer Clinical Trials

Find clinical trials for ovarian cancer. Search for ovarian cancer clinical trials in different cities and states across the United States.

Filter
1
Active & Responsive

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

for
Advanced or Metastatic Solid Tumors, Breast Cancer,
Location: 21 recruiting locations
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT05787587

Phase1, Recruiting
Active & Responsive

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

for
Solid Tumor, Adult, Colorectal Cancer,
Location: 13 recruiting locations
Sponsor: A2 Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT04981119

Recruiting
Active & Responsive

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

for
Ovarian Cancer
Location: 9 recruiting locations
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 50 - 70+

Code: NCT00539162

Recruiting
Active & Responsive

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

for
Gynecologic Cancer, Ovarian Cancer, Fallopian Tube Cancer,
Location: 1 recruiting location
Sponsor: Masonic Cancer Center, University of Minnesota

Sex: All

Age: 18+

Code: NCT06342986

Phase1, Recruiting
Active & Responsive

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

for
Hereditary Breast and Ovarian Cancer
Location: 2 recruiting locations
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT05130606

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)

for
Bladder Cancer, Breast Cancer, Colon Cancer, Endometrial Cancer,
Location: 1 recruiting location
Sponsor: University of California, San Francisco

Sex: All

Age: 18+

Code: NCT05056077

Recruiting
Active & Responsive

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

for
Platinum-resistant Ovarian Cancer,
Location: 29 recruiting locations
Sponsor: Genelux Corporation

Sex: Female

Age: 18+

Code: NCT05281471

Phase3, Recruiting
Active & Responsive

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

for
Advanced Solid Tumor, Locally Advanced Solid Tumor,
Location: 14 recruiting locations
Sponsor: Ascendis Pharma Oncology Division A/S

Sex: All

Age: 18+

Code: NCT05081609

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: 12 recruiting locations
Sponsor: A2 Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT06051695

Phase1, Phase2, Recruiting
Active & Responsive

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,
Location: 10 recruiting locations
Sponsor: Dren Bio

Sex: All

Age: 18+

Code: NCT06999187

Phase1, Recruiting